Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Gains from Sales and Divestitures (2018 - 2024)

STRATA Skin Sciences (SSKN) has disclosed Gains from Sales and Divestitures for 7 consecutive years, with $2265.0 as the latest value for Q4 2024.

  • Quarterly Gains from Sales and Divestitures fell 87.38% to $2265.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2265.0 through Dec 2024, down 87.38% year-over-year, with the annual reading at $2265.0 for FY2024, 87.38% down from the prior year.
  • Gains from Sales and Divestitures hit $2265.0 in Q4 2024 for STRATA Skin Sciences, roughly flat from $2265.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $158407.0 in Q4 2022 to a low of $1414.0 in Q2 2024.
  • Historically, Gains from Sales and Divestitures has averaged $64465.6 across 5 years, with a median of $55547.0 in 2020.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 298.66% in 2023 and later tumbled 98.23% in 2024.
  • Year by year, Gains from Sales and Divestitures stood at $68091.0 in 2020, then surged by 114.95% to $146364.0 in 2021, then rose by 8.23% to $158407.0 in 2022, then plummeted by 88.67% to $17944.0 in 2023, then plummeted by 87.38% to $2265.0 in 2024.
  • Business Quant data shows Gains from Sales and Divestitures for SSKN at $2265.0 in Q4 2024, $2265.0 in Q3 2024, and $1414.0 in Q2 2024.